LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 1,437 pages found matching black box- Reglan Could Leave you 'Twitching' for More - Forever
Aug-9-07 Rockville, MD After discovering what some people go through with Reglan , one can't help being left with the feeling that the cure is worse than the disease. In this case, the side effects of taking Reglan for heartburn, acid reflux disease and GERD (Gastroesophageal Reflux Disease) could leave you with Tardive Dyskinesia (TD). You would know TD to s... - Stevens Johnson Syndrome: August is Awareness Month
Aug-8-07 Westminster, CO August, 2007 has been designated as Stevens Johnson Syndrome (SJS) Awareness month and has so far been recognized in Colorado, Arizona, Alabama, Connecticut and Tennessee. However, with SJS affecting more than two million Americans and causing more than 140,000 deaths among hospitalized patients each year, the SJS foundation and countless... - Is Avandia Safe? Depends On Who You Talk To
Aug-5-07 Gaithersburg, MD When Dr. David Graham testified at the federal drug panel July 30th, reviewing the fate of diabetes drug Avandia and its alleged relationship to heart attack, stroke and kidney failure, he didn't mince words. "It's well established that rosiglitazone increases congestive heart failure," he said. The drug safety reviewer with the U.S... - Watchdog Group to FDA: Avandia Should Be Removed From the Market
Aug-3-07 Washington, DC: Avandia should be removed from the U.S. market, according to testimony delivered by the consumer watchdog group Public Citizen before a Food and Drug Administration (FDA) advisory committee. Unfortunately, the FDA has not heeded the call of Public Citizen and other advocacy groups. The advisory committee voted 22-1 in favor of allowing... - FDA Avandia Panel Faces Scrutiny from Scientists, Health Advocates
Aug-2-07 New York, NY "I logically can't find any way to leave this drug on the market," states Arthur Levin, director of the Center for Medical Consumers in New York. The drug Levin refers to is Avandia . On July 31, Mr. Levin was the lone dissenting member of the US Food and Drug Administration (FDA) advisory committee that voted 22 to 1 to allow Avandia to r... - August Issue of Diabetes Care Documents Avandia Risks: Critics Assail FDA Panel
Aug-1-07 Indianapolis, IN: Yet another study has associated heart problems with the diabetes drug Avandia . The study, published in the August edition of the clinical journal Diabetes Care, comes hot on the heels of a scandal at the FDA over a July 30 decision to allow the controversial drug to stay on the market. 1 out of 50 Users May Be at Risk For the ne... - Lawsuits Against Glaxo Rise as Avandia Sales Plummet
Aug-1-07 Washington, DC: A study released in July 2007, by the Federal Agency for Health Care Research and Quality, reported that the older diabetes drugs, available for as little as $10 a month, are as safe and effective as the newer drugs like Avandia (rosiglitazone), which costs between $131 and $262 a month. On July 20, 2007, Science Daily reported that li... - Kidney failure patients warned of health risk in MRIs
Jul-29-07 Boston, MA: A case report published July 12 in the New England Journal of Medicine tells the story of a 70-year-old man with kidney failure who developed the classic symptoms of having been exposed to gadolinium during one or more MRI s. Over the course of four years following a kidney transplant operation, he became seriously disabled by nephrogenic fib... - Avandia Warnings might have prevented a Death
Jul-27-07 Dallas, TX Neil Pender's father passed away five years ago from a heart attack and he is angry. "My father started taking Avandia shortly after it was approved in 1999 but we didn't hear about the dangers of this drug until June of this year," says Pender. "My father, Roy, wasn't aware that he was a diabetic, but he did have high blood pressure," say... - OxyContin officials spared jail
Jul-21-07 Abington, VA As a drug, OxyContin has been getting a bad rap. Recently in the news for allegations of misbranding and suspect marketing practices by its manufacturer and abuse by addicts and youths, the OxyContin debacle appears to be a case of a worthy product taken advantage of by greedy profiteers and a lax regulatory framework. It is telling that,... - MRI risks Not Only for those with Kidney Failure
Jul-19-07 Washington, DC A common ingredient in the drugs used in magnetic resonance imaging (MRI), gadolinium, has recently been declared risky for patients with kidney failure. But interestingly, anyone undergoing an MRI is at some risk because of the intensity of the magnetic force within the scanner. Patients with kidney failure are now known to be at ri... - Ketek: Justifying the Risks
Jul-17-07 Bridgewater, NJ For some reason, the US Food and Drug Administration (FDA) felt that the benefits of using Ketek outweighed the risks, even though those risks include liver failure and possible death. The FDA approved the drug to treat mild sinus infections - infections that usually clear up on their own in a few days. Ketek was approved even though t... - Ketek Approval Still Haunting FDA Part II
Jul-12-07 Rockville MD: The doctor involved in the Ketek trial has been charged for her actions and sentenced to 57 months in prison after pleading guilty to one count of mail fraud. She enrolled 400 patients into the study, more than any other doctor. At the rate Sanofi-Aventis offered per patient, $400, that was a lot of extra income. Her illegal actions alleged... - MRIs: A New Risk for People with CKD and Kidney Failure
Jul-11-07 New York, NY: As if living with kidney failure and chronic kidney disease (CKD) weren't enough alone—it is now known that people suffering from kidney impairment face a dangerous problem if they undergo an MRI . It turns out that they are at risk to develop a serious illness--Nephrogenic Systemic Fibrosis or NSF—from the gadolinium used as... - Scientists Demand Action on Avandia: New FDA Panels Formed
Jul-8-07 Cleveland, OH: At the recent American Diabetes Association's annual meeting in Chicago, Dr. Steven Nissen, chief of cardiology at the Cleveland Clinic, said early data on links between Avandia and cardiac events were ignored by the drug's maker, Glaxo Smith Klein, including findings presented at the FDA advisory meeting prior to Avandia's approval. "... - New MRI Drug may aggravate Kidney Health Risk
Jul-3-07 Seoul, Korea A magnetic resonance imaging MRI based on the drug gadolinium has been implicated in serious adverse reactions in patients with kidney failure. The MRI drugs are called contrast agents. These contrast agents are chemicals injected into the blood stream before the MRI scan takes place. Because the nanoparticles in the agents make the blood... - Problems Associated with Ketek Extend Beyond Liver Problems
Jul-2-07 Washington, DC: The side effect most people think of when they hear the name Ketek is liver failure. However, at least one person has had a different, life-threatening reaction to Ketek; now patients are investigating the possibility of filing lawsuits against the manufacturer Sanofi-Aventis for serious side effects like toxic epidermal necrolysis (TEN)... - Part 2: Avandia, the FDA and the consumer: first lawsuit filed
Jun-25-07 Beaumont, TX: It is now one month since GlaxoSmithKline's popular diabetes drug Avandia was reported to carry with it a higher risk of heart attack—and just two days ago, on June 19, what is likely the first lawsuit blaming Glaxo for contributing to just such a heart attack, was filed. Larry Alan Stanford, 60, of Beaumont, Texas, suffered a hear... - Health Canada Issues Warning on MRI "Contrast Agents"
Jun-23-07 Ottawa, ON Health Canada has added its voice to the growing number of medical bodies warning of the potential danger that contrast agents in MRI scans pose to people with kidney disease. Health Canada, the Canadian government agency that regulates medicine, issued a warning to physicians on March 9, 2007. This was followed up by a press release four days... - Warning to Avandia Patients in Canada
Jun-22-07 Ottawa, ON Avandia Canada patients have been warned to speak with their doctors after a study published in the New England Journal of Medicine found a link between the risk of heart-related problems and Avandia. The study, published last month, combined the results of 42 clinical trials and found that Avandia increased the risk of heart attack by 43...